Selected research
Industry Growth & Trends
Global Polymer Coronary Stents Industry Growth and Trends Forecast to 2032
Market perspective
The global Polymer Coronary Stents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Polymer Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Polymer Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Polymer Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Polymer Coronary Stents include Wego Healthcare, Shandong Huaan Biotechnology, SINOMED, Translumina Therapeutics, SLTL Medical, Scitech Medical, Rontis, REVA Medical and Purple Microport, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Polymer Coronary Stents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Polymer Coronary Stents market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Polymer Coronary Stents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Polymer Coronary Stents.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Polymer Coronary Stents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Polymer Coronary Stents Market by Company
Wego Healthcare
Shandong Huaan Biotechnology
SINOMED
Translumina Therapeutics
SLTL Medical
Scitech Medical
Rontis
REVA Medical
Purple Microport
Meril Life
InSitu Technologies
HEALTHCARE TECHNOLOGY
Eucatech
Elixir Medical
CeloNova BioSciences
Biotronik
AMG International
Amaranth Medical Analytics
Alvimedica
Polymer Coronary Stents Segment by Type
Hybrid Stents
Biodegradable Polymer Stents
Resorbable Polymer Stents
Bare Metal Polymer Stents
Drug-Eluting Polymer Stents
Polymer Coronary Stents Segment by Application
Drug-Eluting
Post-Procedure Management
Percutaneous Coronary Intervention (PCI)
Polymer Coronary Stents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymer Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymer Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymer Coronary Stents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymer Coronary Stents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Polymer Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hybrid Stents
- Biodegradable Polymer Stents
- Resorbable Polymer Stents
- Bare Metal Polymer Stents
- Drug-Eluting Polymer Stents
Applications
- Drug-Eluting
- Post-Procedure Management
- Percutaneous Coronary Intervention (PCI)
Companies covered
- Wego Healthcare
- Shandong Huaan Biotechnology
- SINOMED
- Translumina Therapeutics
- SLTL Medical
- Scitech Medical
- Rontis
- REVA Medical
- Purple Microport
- Meril Life
- InSitu Technologies
- HEALTHCARE TECHNOLOGY
- Eucatech
- Elixir Medical
- CeloNova BioSciences
- Biotronik
- AMG International
- Amaranth Medical Analytics
- Alvimedica
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Polymer Coronary Stents Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Polymer Coronary Stents Sales Estimates and Forecasts (2021-2032)
- 1.3 Polymer Coronary Stents Market by Type
- 1.3.1 Hybrid Stents
- 1.3.2 Biodegradable Polymer Stents
- 1.3.3 Resorbable Polymer Stents
- 1.3.4 Bare Metal Polymer Stents
- 1.3.5 Drug-Eluting Polymer Stents
- 1.4 Global Polymer Coronary Stents Market Size by Type
- 1.4.1 Global Polymer Coronary Stents Market Size Overview by Type (2021-2032)
- 1.4.2 Global Polymer Coronary Stents Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Polymer Coronary Stents Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Polymer Coronary Stents Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Polymer Coronary Stents Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Polymer Coronary Stents Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Polymer Coronary Stents Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Polymer Coronary Stents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Polymer Coronary Stents Industry Trends
- 2.2 Polymer Coronary Stents Industry Drivers
- 2.3 Polymer Coronary Stents Industry Opportunities and Challenges
- 2.4 Polymer Coronary Stents Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Polymer Coronary Stents Revenue (2021-2026)
- 3.2 Global Top Players by Polymer Coronary Stents Sales (2021-2026)
- 3.3 Global Top Players by Polymer Coronary Stents Price (2021-2026)
- 3.4 Global Polymer Coronary Stents Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Polymer Coronary Stents Major Company Production Sites & Headquarters
- 3.6 Global Polymer Coronary Stents Company, Product Type & Application
- 3.7 Global Polymer Coronary Stents Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Polymer Coronary Stents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Polymer Coronary Stents Players Market Share by Revenue in 2025
- 3.8.3 2025 Polymer Coronary Stents Tier 1, Tier 2, and Tier 3
4 Polymer Coronary Stents Regional Status and Outlook
- 4.1 Global Polymer Coronary Stents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Polymer Coronary Stents Historic Market Size by Region
- 4.2.1 Global Polymer Coronary Stents Sales in Volume by Region (2021-2026)
- 4.2.2 Global Polymer Coronary Stents Sales in Value by Region (2021-2026)
- 4.2.3 Global Polymer Coronary Stents Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Polymer Coronary Stents Forecasted Market Size by Region
- 4.3.1 Global Polymer Coronary Stents Sales in Volume by Region (2027-2032)
- 4.3.2 Global Polymer Coronary Stents Sales in Value by Region (2027-2032)
- 4.3.3 Global Polymer Coronary Stents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Polymer Coronary Stents by Application
- 5.1 Polymer Coronary Stents Market by Application
- 5.1.1 Drug-Eluting
- 5.1.2 Post-Procedure Management
- 5.1.3 Percutaneous Coronary Intervention (PCI)
- 5.2 Global Polymer Coronary Stents Market Size by Application
- 5.2.1 Global Polymer Coronary Stents Market Size Overview by Application (2021-2032)
- 5.2.2 Global Polymer Coronary Stents Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Polymer Coronary Stents Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Polymer Coronary Stents Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Polymer Coronary Stents Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Polymer Coronary Stents Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Polymer Coronary Stents Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Polymer Coronary Stents Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Wego Healthcare
- 6.1.1 Wego Healthcare Company Information
- 6.1.2 Wego Healthcare Business Overview
- 6.1.3 Wego Healthcare Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Wego Healthcare Polymer Coronary Stents Product Portfolio
- 6.1.5 Wego Healthcare Recent Developments
- 6.2 Shandong Huaan Biotechnology
- 6.2.1 Shandong Huaan Biotechnology Company Information
- 6.2.2 Shandong Huaan Biotechnology Business Overview
- 6.2.3 Shandong Huaan Biotechnology Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shandong Huaan Biotechnology Polymer Coronary Stents Product Portfolio
- 6.2.5 Shandong Huaan Biotechnology Recent Developments
- 6.3 SINOMED
- 6.3.1 SINOMED Company Information
- 6.3.2 SINOMED Business Overview
- 6.3.3 SINOMED Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 SINOMED Polymer Coronary Stents Product Portfolio
- 6.3.5 SINOMED Recent Developments
- 6.4 Translumina Therapeutics
- 6.4.1 Translumina Therapeutics Company Information
- 6.4.2 Translumina Therapeutics Business Overview
- 6.4.3 Translumina Therapeutics Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Translumina Therapeutics Polymer Coronary Stents Product Portfolio
- 6.4.5 Translumina Therapeutics Recent Developments
- 6.5 SLTL Medical
- 6.5.1 SLTL Medical Company Information
- 6.5.2 SLTL Medical Business Overview
- 6.5.3 SLTL Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 SLTL Medical Polymer Coronary Stents Product Portfolio
- 6.5.5 SLTL Medical Recent Developments
- 6.6 Scitech Medical
- 6.6.1 Scitech Medical Company Information
- 6.6.2 Scitech Medical Business Overview
- 6.6.3 Scitech Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Scitech Medical Polymer Coronary Stents Product Portfolio
- 6.6.5 Scitech Medical Recent Developments
- 6.7 Rontis
- 6.7.1 Rontis Company Information
- 6.7.2 Rontis Business Overview
- 6.7.3 Rontis Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Rontis Polymer Coronary Stents Product Portfolio
- 6.7.5 Rontis Recent Developments
- 6.8 REVA Medical
- 6.8.1 REVA Medical Company Information
- 6.8.2 REVA Medical Business Overview
- 6.8.3 REVA Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 REVA Medical Polymer Coronary Stents Product Portfolio
- 6.8.5 REVA Medical Recent Developments
- 6.9 Purple Microport
- 6.9.1 Purple Microport Company Information
- 6.9.2 Purple Microport Business Overview
- 6.9.3 Purple Microport Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Purple Microport Polymer Coronary Stents Product Portfolio
- 6.9.5 Purple Microport Recent Developments
- 6.10 Meril Life
- 6.10.1 Meril Life Company Information
- 6.10.2 Meril Life Business Overview
- 6.10.3 Meril Life Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Meril Life Polymer Coronary Stents Product Portfolio
- 6.10.5 Meril Life Recent Developments
- 6.11 InSitu Technologies
- 6.11.1 InSitu Technologies Company Information
- 6.11.2 InSitu Technologies Business Overview
- 6.11.3 InSitu Technologies Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 InSitu Technologies Polymer Coronary Stents Product Portfolio
- 6.11.5 InSitu Technologies Recent Developments
- 6.12 HEALTHCARE TECHNOLOGY
- 6.12.1 HEALTHCARE TECHNOLOGY Company Information
- 6.12.2 HEALTHCARE TECHNOLOGY Business Overview
- 6.12.3 HEALTHCARE TECHNOLOGY Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 HEALTHCARE TECHNOLOGY Polymer Coronary Stents Product Portfolio
- 6.12.5 HEALTHCARE TECHNOLOGY Recent Developments
- 6.13 Eucatech
- 6.13.1 Eucatech Company Information
- 6.13.2 Eucatech Business Overview
- 6.13.3 Eucatech Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Eucatech Polymer Coronary Stents Product Portfolio
- 6.13.5 Eucatech Recent Developments
- 6.14 Elixir Medical
- 6.14.1 Elixir Medical Company Information
- 6.14.2 Elixir Medical Business Overview
- 6.14.3 Elixir Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Elixir Medical Polymer Coronary Stents Product Portfolio
- 6.14.5 Elixir Medical Recent Developments
- 6.15 CeloNova BioSciences
- 6.15.1 CeloNova BioSciences Company Information
- 6.15.2 CeloNova BioSciences Business Overview
- 6.15.3 CeloNova BioSciences Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 CeloNova BioSciences Polymer Coronary Stents Product Portfolio
- 6.15.5 CeloNova BioSciences Recent Developments
- 6.16 Biotronik
- 6.16.1 Biotronik Company Information
- 6.16.2 Biotronik Business Overview
- 6.16.3 Biotronik Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Biotronik Polymer Coronary Stents Product Portfolio
- 6.16.5 Biotronik Recent Developments
- 6.17 AMG International
- 6.17.1 AMG International Company Information
- 6.17.2 AMG International Business Overview
- 6.17.3 AMG International Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 AMG International Polymer Coronary Stents Product Portfolio
- 6.17.5 AMG International Recent Developments
- 6.18 Amaranth Medical Analytics
- 6.18.1 Amaranth Medical Analytics Company Information
- 6.18.2 Amaranth Medical Analytics Business Overview
- 6.18.3 Amaranth Medical Analytics Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Amaranth Medical Analytics Polymer Coronary Stents Product Portfolio
- 6.18.5 Amaranth Medical Analytics Recent Developments
- 6.19 Alvimedica
- 6.19.1 Alvimedica Company Information
- 6.19.2 Alvimedica Business Overview
- 6.19.3 Alvimedica Polymer Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Alvimedica Polymer Coronary Stents Product Portfolio
- 6.19.5 Alvimedica Recent Developments
7 North America by Country
- 7.1 North America Polymer Coronary Stents Sales by Country
- 7.1.1 North America Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Polymer Coronary Stents Sales by Country (2021-2026)
- 7.1.3 North America Polymer Coronary Stents Sales Forecast by Country (2027-2032)
- 7.2 North America Polymer Coronary Stents Market Size by Country
- 7.2.1 North America Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Polymer Coronary Stents Market Size by Country (2021-2026)
- 7.2.3 North America Polymer Coronary Stents Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Polymer Coronary Stents Sales by Country
- 8.1.1 Europe Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Polymer Coronary Stents Sales by Country (2021-2026)
- 8.1.3 Europe Polymer Coronary Stents Sales Forecast by Country (2027-2032)
- 8.2 Europe Polymer Coronary Stents Market Size by Country
- 8.2.1 Europe Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Polymer Coronary Stents Market Size by Country (2021-2026)
- 8.2.3 Europe Polymer Coronary Stents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Polymer Coronary Stents Sales by Country
- 9.1.1 Asia-Pacific Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Polymer Coronary Stents Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Polymer Coronary Stents Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Polymer Coronary Stents Market Size by Country
- 9.2.1 Asia-Pacific Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Polymer Coronary Stents Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Polymer Coronary Stents Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Polymer Coronary Stents Sales by Country
- 10.1.1 South America Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Polymer Coronary Stents Sales by Country (2021-2026)
- 10.1.3 South America Polymer Coronary Stents Sales Forecast by Country (2027-2032)
- 10.2 South America Polymer Coronary Stents Market Size by Country
- 10.2.1 South America Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Polymer Coronary Stents Market Size by Country (2021-2026)
- 10.2.3 South America Polymer Coronary Stents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Polymer Coronary Stents Sales by Country
- 11.1.1 Middle East and Africa Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Polymer Coronary Stents Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Polymer Coronary Stents Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Polymer Coronary Stents Market Size by Country
- 11.2.1 Middle East and Africa Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Polymer Coronary Stents Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Polymer Coronary Stents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Polymer Coronary Stents Value Chain Analysis
- 12.1.1 Polymer Coronary Stents Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Polymer Coronary Stents Production Mode & Process
- 12.2 Polymer Coronary Stents Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Polymer Coronary Stents Distributors
- 12.2.3 Polymer Coronary Stents Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst